Healthcare | May 08, 2024
Sumitomo Corporation makes full-scale entry into private clinic business in fast-growing southeast Asia
Investing in Malaysia's largest clinic operator to expand the healthcare business
Investing in Malaysia's largest clinic operator to expand the healthcare business
Subcutaneous nivolumab has potential to be the first and only subcutaneously administered PD-1 inhibitor
Sales reflect continued strong growth in oncology and vaccines
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
Longest survival follow-up ever reported for immunotherapy treatment in this setting
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market
To accelerate the development of next-generation radioconjugates to treat cancer
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
The investment will catalyse various components of the IndiaAI Mission
Subscribe To Our Newsletter & Stay Updated
